Ming Chen, Yongling Ji, Long Chen, Qingsong Pang, Ou Jiang, Hong Ge, Yufeng Cheng, Rongrong Zhou, Xiangjiao Meng, Xuhong Min, Hui Wang, Haihua Yang, Yue Xie, Anping Zheng, Jie Li, Bing Xia, Desheng Hu, Xi Zhang, Yong Chen, Wenhui Li. "R-ALPS: A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of TQB2450 with or without anlotinib as maintenance treatment in patients with locally advanced and unresectable (stage III) NSCLC without progression following concurrent or sequential chemoradiotherapy.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.17_suppl.lba8004